참고문헌
- Titorencu I, Pruna V, Jinga VV, Simionescu M. 2014. Osteoblast ontogeny and implications for bone pathology: an overview. Cell Tissue Res 355: 23-33. https://doi.org/10.1007/s00441-013-1750-3
- Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science 289: 1508-1514. https://doi.org/10.1126/science.289.5484.1508
- Walsh MC, Kim N, Kadono Y, Rho J, Lee SY, Lorenzo J, Choi Y. 2006. Osteoimmunology: interplay between the immune system and bone metabolism. Annu Rev Immunol 24: 33-63. https://doi.org/10.1146/annurev.immunol.24.021605.090646
- Wang C, Wang X, Xu XL, Yuan XL, Gou WL, Wang AY, Guo QY, Peng J, Lu SB. 2014. Bone microstructure and regional distribution of osteoblast and osteoclast activity in the osteonecrotic femoral head. PLoS ONE 9: e96361. https://doi.org/10.1371/journal.pone.0096361
- Beederman M, Farina EM, Reid RR. 2014. Molecular basis of cranial suture biology and disease: Osteoblastic and osteoclastic perspectives. Genes Dis 1: 120-125. https://doi.org/10.1016/j.gendis.2014.07.004
- Tsubaki M, Komai M, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S. 2014. Nitrogen-containing bisphosphonates inhibit RANKL- and MCSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation. J Biomed Sci 21: 10. https://doi.org/10.1186/1423-0127-21-10
- Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176. https://doi.org/10.1016/S0092-8674(00)81569-X
- Soysa NS, Alles N, Shimokawa H, Jimi E, Aoki K, Ohya K. 2009. Inhibition of the classical NF-kappaB pathway prevents osteoclast bone-resorbing activity. J Bone Miner Metab 27: 131-139. https://doi.org/10.1007/s00774-008-0026-6
- Takeda S, Yoshizawa T, Nagai Y, Yamato H, Fukumoto S, Sekine K, Kato S, Matsumoto T, Fujita T. 1999. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. Endocrinology 140: 1005-1008. https://doi.org/10.1210/endo.140.2.6673
-
Miyaura C, Inada M, Matsumoto C, Ohshiba T, Uozumi N, Shimizu T, Ito A. 2003. An essential role of cytosolic phospholipase
$A2{\alpha}$ in prostaglandin E2-mediated bone resorption associated with inflammation. J Exp Med 197: 1303-1310. https://doi.org/10.1084/jem.20030015 - Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL. 2005. IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 115: 282-290. https://doi.org/10.1172/JCI200523394
- Feng X, McDonald JM. 2011. Disorders of bone remodeling. Annu Rev Pathol 6: 121-145. https://doi.org/10.1146/annurev-pathol-011110-130203
-
Kim HJ, Yoon HJ, Kim SY, Yoon YR. 2014. A mediumchain fatty acid, capric acid, inhibits RANKL-induced osteoclast differentiation via the suppression of NF-
${\kappa}B$ signaling and blocks cytoskeletal organization and survival in mature osteoclasts. Mol Cells 37: 598-604. https://doi.org/10.14348/molcells.2014.0153 -
Li DZ, Zhang QX, Dong XX, Li HD, Ma X. 2014. Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-
${\kappa}B$ pathways in murine RAW264.7 cells. J Bone Miner Metab 32: 494-504. https://doi.org/10.1007/s00774-013-0530-1 - Wagner EF, Eferl R. 2005. Fos/AP-1 proteins in bone and the immune system. Immunol Rev 208: 126-140. https://doi.org/10.1111/j.0105-2896.2005.00332.x
- Teitelbaum SL, Ross FP. 2003. Genetic regulation of osteoclast development and function. Nat Rev Genet 4: 638-649. https://doi.org/10.1038/nrg1122
- Kim JH, Kim N. 2014. Regulation of NFATc1 in osteoclast differentiation. J Bone Metab 21: 233-241. https://doi.org/10.11005/jbm.2014.21.4.233
-
Kavitha CV, Deep G, Gangar SC, Jain AK, Agarwal C, Agarwal R. 2014. Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-
${\kappa}B$ , and AP-1 activation in RAW264.7 cells. Mol Carcinog 53: 169-180. https://doi.org/10.1002/mc.21959 - Battaglino R, Kim D, Fu J, Vaage B, Fu XY, Stashenko P. 2002. c-myc is required for osteoclast differentiation. J Bone Miner Res 17: 763-773. https://doi.org/10.1359/jbmr.2002.17.5.763
- Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L. 1997. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendriticcell function. Nature 390: 175-179. https://doi.org/10.1038/36593
- Lee MH, Han JS, Kozukue N, Minamide T. 2005. Physicochemical characteristics of commercial spinach produced in autumn. J East Asian Soc Dietary Life 15: 306-314.
- Kim NY, Yoon SK, Jang MS. 1993. Effect of blanching on the chemical properties of different kind of spinach. Korean J Soc Food Sci 9: 204-209.
- Lomnitski L, Bergman M, Nyska A, Ben-Shaul V, Grossman S. 2003. Composition, efficacy, and safety of spinach extracts. Nutr Cancer 46: 222-231. https://doi.org/10.1207/S15327914NC4602_16
- Bohlooli S, Barmaki S, Khoshkhahesh F, Nakhostin-Roohi B. 2014. The effect of spinach supplementation on exerciseinduced oxidative stress. J Sports Med Phys Fitness [Epub ahead of print].
- Ko SH, Park JH, Kim SY, Lee SW, Chun SS, Park E. 2014. Antioxidant effects of spinach (Spinacia oleracea L.) supplementation in hyperlipidemic rats. Prev Nutr Food Sci 19: 19-26. https://doi.org/10.3746/pnf.2014.19.1.019
- Seo JH, Kang HW, Han JS. 2012. Quality characteristics of Jajang noodles with added spinach. J East Asian Soc Dietary Life 22: 278-289.
- Moon HJ, Ko WK, Han SW, Kim DS, Hwang YS, Park HK, Kwon IK. 2012. Antioxidants, like coenzyme Q10, selenite, and curcumin, inhibited osteoclast differentiation by suppressing reactive oxygen species generation. Biochem Biophys Res Commun 418: 247-253. https://doi.org/10.1016/j.bbrc.2012.01.005
- Lee JH, Kim HN, Yang D, Jung K, Kim HM, Kim HH, Ha H, Lee ZH. 2009. Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling. J Biol Chem 284: 13725-13734. https://doi.org/10.1074/jbc.M806941200
-
Sriarj W, Aoki K, Ohya K, Takahashi M, Takagi Y, Shimokawa H. 2015. TGF-
${\beta}$ in dentin matrix extract induces osteoclastogenesis in vitro. Odontology 103: 9-18. https://doi.org/10.1007/s10266-013-0140-3 - de Kok JB, Roelofs RW, Giesendorf BA, Pennings JL, Waas ET, Feuth T, Swinkels DW, Span PN. 2005. Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Lab Invest 85: 154-159. https://doi.org/10.1038/labinvest.3700208
- Liu YQ, Zhan LB, Liu T, Cheng MC, Liu XY, Xiao HB. 2014. Inhibitory effect of Ecliptae herba extract and its component wedelolactone on pre-osteoclastic proliferation and differentiation. J Ethnopharmacol 157: 206-211. https://doi.org/10.1016/j.jep.2014.09.033
- Lee SE, Woo KM, Kim SY, Kim HM, Kwack K, Lee ZH, Kim HH. 2002. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 30: 71-77.
-
Chung YH, Choi B, Song DH, Song Y, Kang SW, Yoon SY, Kim SW, Lee HK, Chang EJ. 2014. Interleukin-
$1{\beta}$ promotes the LC3-mediated secretory function of osteoclast precursors by stimulating the$Ca^{2+}$ -dependent activation of ERK. Int J Biochem Cell Biol 54: 198-207. https://doi.org/10.1016/j.biocel.2014.07.018
피인용 문헌
- RANKL 유도된 파골세포 분화에 대한 풀무치 에탄올 추출물의 분화 억제 효과 vol.29, pp.10, 2019, https://doi.org/10.5352/jls.2019.29.10.1104
- 갈색거저리 유충 에탄올 추출물이 RANKL에 의해 유도되는 파골세포 분화에 미치는 영향 vol.30, pp.11, 2020, https://doi.org/10.5352/jls.2020.30.11.983